Buy-and-Bill

Latest News

October 8th 2025

Tailoring Psoriasis Therapy for Adherence, Comorbidities, and Hard-to-Treat Areas

Explore real-world psoriasis management insights from Anthony Nuara, MD, PhD, focusing on patient-centered approaches and innovative treatments like tildrakizumab.

September 2nd 2025

Adherence Challenges Take Center Stage in Psoriasis Management

By Maddi Hebebrand, MC, Associate Editor

August 22nd 2025

Tailoring Psoriasis Care to Patients, Not Just Protocols

By Maddi Hebebrand, MC, Associate Editor

February 3rd 2025

Initiating and Navigating the Buy-and-Bill Process

By Maddi Hebebrand, MC, Associate Editor, Omar Noor, MD, FAAD

January 27th 2025

Enhancing Patient Care Through Innovation

By Maddi Hebebrand, MC, Associate Editor, Omar Noor, MD, FAAD

CME Content

Video

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Corey Cutler, MD, MPH, FRCP(C); Amin M. Alousi, MD; Mehdi Hamadani, MD; Anna Sureda, MD, PhD

In-Person Event

Show Me the Data: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD

February 7, 2026

Register now!

Multimedia

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Hilary Baldwin; Neal Bhatia, MD

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Video

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc

Video

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD

When and How to Employ the Buy and Bill Model

ByMaddi Hebebrand, MC, Associate Editor,Omar Noor, MD, FAAD

January 20th 2025

Noor emphasizes that patient access is the primary consideration when deciding to use the buy-and-bill model.

Understanding Buy and Bill for Medical Dermatology: A Win-Win

ByAaron S. Farberg, MD

May 7th 2024

Dermatology Times' Spring Editor in Chief, Aaron Farberg, MD, discusses the business strategy known as buy and bill.

Buy-and-Bill

Latest News

CME Content

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Show Me the Data: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

When and How to Employ the Buy and Bill Model

Understanding Buy and Bill for Medical Dermatology: A Win-Win

Trending on Dermatology Times

FDA Grants Breakthrough Therapy Designation to Litifilimab for Cutaneous Lupus Erythematosus

Del Rosso's What's New in the Medicine Chest 2026: CHE, CSU, and Vitiligo

Multi-Ingredient Topical Treatment Significantly Improves Wrinkles and Skin Thickness in Patients with "Ozempic Face"

Beyond Weight Loss: Clinical Perspectives on GLP-1s for Inflammatory Dermatoses

Dermatology Times January 2026 Print Recap